• There are no suggestions because the search field is empty.

Technovigilance in Action: Safeguarding Health with Post-Market Surveillance of Medical Devices

Author Avatar
QbD Group
Vigilance
Medical Devices
Pharma & Biotech

Learn how technovigilance ensures medical device safety through post-market surveillance, tackling risks, compliance, and best practices.

Technovigilance: Safeguarding Health with Medical Device Surveillance
8:48

With rapid advancements in medical technology reshaping healthcare, new devices and innovations are emerging faster than ever before. From innovative diagnostic tools to cutting-edge implants and wearable devices, these advancements hold immense potential. But with great innovation comes the need for heightened vigilance.How do we ensure that these devices, designed to save and improve lives, do not inadvertently introduce new risks? This is where technovigilance comes into play.


A relatively new yet crucial field, technovigilance is all about keeping a close watch on medical devices after they hit the market, making sure they are safe, effective, and reliable for all users. In this blog post, we will explore the importance of technovigilance, its key components, the challenges it faces, and best practices for manufacturers and healthcare providers to ensure the highest standards of safety and efficacy.

 

What is Technovigilance?

Technovigilance is a comprehensive set of standards, mechanisms, processes, and resources dedicated to the identification, evaluation, and management of adverse events and technical complaints associated with medical devices and health-related products. These products range from medical equipment and hospital supplies to implants and in-vitro diagnostic tools.

Unlike pre-market assessments, which focus on evaluating devices before they are introduced to the public, technovigilance emphasizes the post-marketing phase, where real-world data and user experiences are critical for ongoing safety assessment.

A key component of technovigilance involves complying with established regulations, such as the COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993, which sets out the legal obligations for manufacturers regarding the monitoring and reporting of adverse effects related to their health products.

This directive mandates not only the detection and documentation of any undesirable effects but also their prompt reporting to competent authorities. This rigorous approach ensures that issues are addressed swiftly, minimizing potential harm to patients and users while maintaining public trust in medical devices.

 

 The Growing Need for Technovigilance

The scope of technovigilance is vast and ever-growing. According to the 'Global Atlas of Medical Devices' published by the World Health Organization (WHO) in 2017, there were an estimated 2 million different types of medical devices available on the global market. These are categorized into various device groups, each with unique properties, potential benefits, and risks.

With the rapid technological advancements expected in the coming years, this number is only set to increase, adding layers of complexity to the already challenging task of health product surveillance.

The sheer diversity and rapid innovation in medical devices make technovigilance an exceptionally specialized area. It requires not just a superficial understanding but in-depth knowledge across multiple domains—scientific, technical, legal, and clinical. As such, a multidisciplinary approach is critical.

Teams comprising scientists, engineers, healthcare professionals, regulatory experts, and legal advisors must collaborate closely to ensure a robust surveillance system that can keep pace with the dynamic landscape of medical technology.

 Why is Technovigilance So Crucial Today?

In an era where healthcare technology is becoming increasingly sophisticated, the margin for error must be minimized. Technovigilance serves as the frontline defense in ensuring that the advanced medical devices meant to improve and save lives do not inadvertently cause harm.

With technologies like AI-driven diagnostic tools, wearable health monitors, and smart implants entering the market, the potential for both positive impact and unforeseen risks has never been higher. This dual potential reinforces the need for rigorous technovigilance practices.

The importance of technovigilance cannot be understated—it’s not just about addressing problems after they arise but also about anticipating and preventing them. This proactive stance helps build trust with consumers and stakeholders, ensuring that innovations in medical technology translate into genuine health benefits rather than new categories of risk.

 Key Challenges in Technovigilance

While technovigilance is crucial, it also comes with its set of challenges. Below are some of the most pressing challenges faced by the industry:

 

Data Privacy and Security Concerns

One significant challenge is data privacy and security. As technovigilance relies heavily on collecting and analyzing data from various sources—ranging from healthcare providers to real-time data from IoT-enabled medical devices—ensuring the confidentiality and security of this data is paramount. Breaches or mishandling of sensitive patient information can lead to legal consequences and erode public trust.

Under-Reporting of Adverse Events

Another challenge is the under-reporting of adverse events. Many healthcare providers may not report minor issues, or there could be delays in reporting due to bureaucratic hurdles or lack of awareness. This under-reporting can skew data, making it harder to identify potential risks early on.

Diverse Global Regulations

The global diversity in regulations poses a significant hurdle. Different countries have different standards, reporting requirements, and monitoring systems, making it challenging for manufacturers operating in multiple markets to maintain compliance across all jurisdictions. The lack of a globally harmonized regulatory framework can lead to discrepancies and gaps in surveillance.

 

Best Practices for Manufacturers and Healthcare Providers

To overcome these challenges, it’s essential for manufacturers and healthcare providers to adopt best practices in technovigilance:

 

1. Establish a Robust Reporting System

Develop a streamlined system that encourages the timely reporting of adverse events and technical complaints. Training staff on the importance of reporting and how to do it efficiently can significantly reduce under-reporting.

2. Leverage Technology for Data Analysis

Utilize advanced data analytics and machine learning tools to analyze data from various sources, identify patterns, and predict potential risks before they escalate. Investing in these technologies can provide a proactive approach to risk management.

3. Ensure Compliance Across Markets

For global manufacturers, understanding and complying with different regional regulations is crucial. This may require dedicated teams or consultants who specialize in regulatory affairs for each region.

4. Focus on Data Privacy and Security

Implement strong data protection measures to ensure that patient data and sensitive information are safeguarded. This includes regular audits, encryption, and ensuring compliance with data privacy laws like GDPR.

5. Foster a Multidisciplinary Approach

A successful technovigilance program requires collaboration among various experts, including regulatory professionals, scientists, engineers, and legal advisors. Establishing a multidisciplinary team ensures a comprehensive approach to managing potential risks.

 
 

Partnering for Excellence in Technovigilance

The complex landscape of technovigilance demands a strategic approach and expert guidance. This is where partnering with specialists can make a significant difference.

By collaborating with experienced professionals, manufacturers and healthcare providers can more effectively address these challenges, ensuring that their surveillance systems are both robust and compliant across diverse markets.

At QbD Group, we specialize in comprehensive technovigilance solutions tailored to meet the unique needs of our clients.

Our experts are well-versed in the nuances of regulatory requirements, risk management, and technological surveillance, ensuring that you are always a step ahead in maintaining compliance and protecting consumer well-being.

Whether you have questions about specific technovigilance processes or need end-to-end support to navigate this complex field, we’re here to help.

 

 
 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Whitepaper

A Complete Guide to Computer System Validation

This guide aims to bring context and define the necessary and appropriate strategies for the validation of computerized systems. Download now.
preview_image
Whitepaper

Digital Health - Exploring the landscape and future opportunities

This whitepaper informs you about digital health, key technology pillars, and new opportunities to anticipate future trends in your healthcare sector.
preview_image
Whitepaper

ISO 13485:2016 - Compliance Checklist

Are you up to date with the latest medical device QMS requirements? Download our free ISO 13485:2016 checklist to ensure compliance.
preview_image
Case study

Enhancing data integrity & aseptic manufacturing compliance

QbD Group helped a leading medical tech company improve MDR compliance and enhance aseptic manufacturing for long-term regulatory readiness.
preview_image
Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.
preview_image
Whitepaper

ICH Stability Studies on Pharmaceuticals

This whitepaper discusses the importance of different methods for testing the stability of pharmaceutical products, stability study guidelines, and other aspects related to the stability of pharmaceutical products.
preview_image
Whitepaper

EU GMP: How to import your products into the EU?

Are you a medicinal product manufacturer looking to import your products into the EU in line with the latest EU-GMP import regulations? Download our guide.
preview_image
Case study

Scalable MSAT validation support for seamless compliance & efficiency

Discover how QbD Group helped a global pharmaceutical company address fluctuating validation demands across multiple teams.
preview_image
Case study

Restoring manufacturing timelines through expert deviation management

Discover how QbD Group helped a leading biotechnology company overcome a backlog of deviations, restoring timely batch release through expert QA support.
preview_image
Case study

Guiding a global biotech company through ATMP facility qualification

Discover how QbD Group supported a global biotech company in commissioning and qualifying two ATMP therapy production sites, ensuring compliance and efficiency.
preview_image
Whitepaper

How to keep computerized systems in the operational phase

Ensure compliance and efficiency with best practices for maintaining computerized systems in the operational phase. Download our expert whitepaper now!
preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Webinar

Evidence Throughout the Lifecycle: Integrating Clinical Needs into Design & Documentation

Discover how to integrate clinical needs into medical device software design to meet MDR requirements. Watch our webinar on demand.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Webinar

From Requirements to Code: a unified MDSW development cycle that covers all requirements

Watch our webinar on demand to master medical device software development. Learn about IEC standards, cybersecurity, AI integration, and FDA expectations.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

From Concept to Market: Comprehensive Market Access Strategies for Medical Device Software

Learn how to launch your Medical Device Software successfully with expert insights on market access and commercialization strategies. Watch our webinar on demand.
preview_image
Whitepaper

State-of-the-art literature review: kick off the Clinical Evaluation of your Medical Device

This whitepaper will walk you through the steps of conducting solid systematic SOTA literature searches for your clinical evaluation. Download now.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Whitepaper

The pathway from idea to patient under MDR

This guide explains the pathway and steps needed to test your device in human subjects, aiming to get your product to market. Download now.
preview_image
Webinar

Unlocking Strategic Value in Drug Safety for Life Sciences Organizations

Explore how drug safety teams can transform into proactive benefit drivers with the right tools & resources in this webinar on demand.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.
preview_image
Whitepaper

GAMP 5 Software Validation Approach for GMP, GCP and GLP regulations

Learn how to comply with GMP, GCP, and GLP regulations using the GAMP 5 Software Validation Approach. Download the whitepaper for more insights.
preview_image
Webinar

How to manage mandatory communication of Toxicological Risks?

Learn how to effectively manage toxicological risks in the pharmaceutical industry by addressing, reporting, and mitigating potential harm.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Whitepaper

Standards and regulations for software used in Medical Devices

Explore the essential standards and regulations for software used in Medical Devices, including IEC 62304 and IEC 82304. Download now.
preview_image
Webinar

Setting up ATMP Quality Management Systems: Strategies for Compliance and Success

Discover strategies for establishing a compliant and successful ATMP Quality Management System. Watch our webinar on demand.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Webinar

The Basic Concepts of the QbD Methodology

Learn the basics of QbD methodology with industry experts in this on-demand webinar.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Webinar

ATMP Supply Chain: Navigating the Challenges and Exploring the Vein-to-Vein Strategy

Explore the transformative ATMP journey and vein-to-vein strategy in our webinar. Learn how to navigate challenges and unlock the full potential of ATMPs.
preview_image
Whitepaper

Achieving laboratory compliance

This whitepaper explores the multifaceted aspects of laboratory compliance, including data integrity, quality control measures, and regulatory adherence.
preview_image
Whitepaper

Annual Product Quality Review in Pharma

Want to learn more about the importance, benefits, and key challenges related to the Annual Product Quality Review in Pharma? Then read on quickly!
preview_image
Whitepaper

New GMP Facility Qualification: set-up, process and best practices

This whitepaper delves into the challenges of establishing a new GMP facility, focusing on potential pitfalls and best practices. Download now.
preview_image
Whitepaper

The One-Vigilance strategic roadmap to corporate excellence

This whitepaper introduces the concept of One Vigilance within the context of the current drug safety landscape. Download now.
preview_image
Case study

Guiding KU Leuven's glioblastoma research to the clinic with precision business planning

Helping KU Leuven advance glioblastoma research to the clinic with strategic business planning, funding support, and a roadmap for clinical impact.
preview_image
Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.
preview_image
Whitepaper

21 CFR Part 11 compliance checklist

Want to assess whether a computer system generates electronic records and uses electronic signatures, and whether the system complies with Part 11 of 21 CFR? Download this free checklist.
preview_image
Whitepaper

Ensuring compliance and quality in Pharmacovigilance

The whitepaper emphasizes the importance of a robust pharmacovigilance QMS and a well-maintained Pharmacovigilance System Master File (PSMF). Download now.
preview_image
Webinar

Second edition of GAMP 5: A Risk-Based Approach to compliant GxP Computerized Systems

This webinar on demand will tell you more about the second edition of GAMP 5.
preview_image
Whitepaper

Organic and mutagenic impurities in pharma

Ensure pharmaceutical quality and safety by controlling organic and mutagenic impurities. Download this whitepaper to learn more.
preview_image
Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.
preview_image
Webinar

Verification & Validation of Artificial Intelligence/ Machine Learning Medical Devices

Explore the impact of Artificial Intelligence and Machine Learning on medical device validation and verification processes.
preview_image
Whitepaper

GAMP categories for computerized systems: what are they and what are they for?

In this whitepaper, you will learn what GAMP is, what GAMP categories are for, and where to start if you are facing computerized systems validation.
preview_image
Whitepaper

Analytical Method Validation

In this whitepaper, we will give an overview of the criteria to consider when validating your analytical method.
preview_image
Whitepaper

EUDRALEX Volume 4 Annex 11 Compliance Checklist

Assess your computer system's compliance with EudraLex Volume 4 Annex 11 guidelines using our checklist. Download now for GMP assurance.
preview_image
Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.
preview_image
Whitepaper

From V-model to Agile: how to embrace automation as part of the computerized system validation approach

This white paper explores why IT is shifting to agile, focuses on the prevalent Scrum methodology, and concludes with guidance on adapting system validation processes.
preview_image
Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.
preview_image
Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.
preview_image
Case study

Optimizing pharmacovigilance for a biotechnology leader

Discover how QbD Group improved pharmacovigilance for a global leader in biotechnology, ensuring regulatory compliance and patient safety.
preview_image
Case study

Ensuring timely launch: QbD Group's role in establishing a hemophilia drug production line

QbD Group has facilitated the launch of a new drug production line for treating hemophilia, overseeing the qualification of over 100 pieces of small-scale supporting equipment.
preview_image
Case study

Ensuring pharmaceutical production quality: cleaning validation for government agency

Discover how QbD Group helped a client tackle dual validation challenges for their production lines, ensuring GMP compliance and AEMPS approval.
preview_image
Case study

Revolutionizing pharmacovigilance: a success story of strategic partnership and seamless integration

Discover how QbD Group's expert support enhanced a pharmaceutical company's pharmacovigilance, leading to a favorable inspection outcome by the local Regulatory Authority (AEMPS).
preview_image
Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Patient Support Program (PSP)

Learn about our patient support program (PSP) and how it helps manage customer support for a PV Spanish client. Resolve quality issues and ensure stability with QbD Pharma.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.
preview_image
Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.
preview_image
Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.
preview_image
Case study

Helping Abraca BioSystems to obtain ISO 13485 certification

QbD Group helped Abraca Biosystem gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Help BioLizard build their Quality Management System

QbD Group helped BioLizard document the fundamental processes of their QMS and enabled them to continue building it on their own.
preview_image
Case study

Supporting Oncomfort in developing and certifying their ISO 13485 QMS

QbD Group helped Oncomfort quickly implement and certify an ISO 13485 compliant Quality Management System.
preview_image
Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.